CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: In conclusion, our study showed that the expression of miR-155 is up-regulated in CD34+ CML cells and revealed a regulatory correlation between miR-155 and TGF-β/SMAD pathway.